Search research articles
Contact Us
Filters
Showing results (231-240 of 456) with videos related to
Page
of 46
Sort By:
Journal of Gastroenterology and Hepatology
|
April 9, 2013
Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin
Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, et al.
Plos One
|
May 13, 2022
Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, et al.
Plos One
|
March 26, 2013
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients
Chung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Journal of Hepatology
|
June 28, 2011
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
Chung-Feng Huang, Jee-Fu Huang, Jeng-Fu Yang, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
December 19, 2012
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
Chung-Feng Huang, Ming-Lung Yu, Jia-Horng Kao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 19, 2017
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Tomi W Jun, Ming-Lun Yeh, Ju Dong Yang, et al.
Medicine
|
March 9, 2018
Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes
Ching-I Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
JHEP Reports : Innovation in Hepatology
|
December 30, 2025
Corrigendum to "Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study" [JHEP Reports 2025 7(10) 101516]
Edward Gane, Ewa Janczewska, Tetsuo Takehara, et al.
JHEP Reports : Innovation in Hepatology
|
September 8, 2025
Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study
Edward Gane, Ewa Janczewska, Tetsuo Takehara, et al.
Alimentary Pharmacology & Therapeutics
|
August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment
Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.
Page
of 46
Search research articles
Search
Showing results (231-240 of 456) with videos related to
Sort By:
Page
of 46
Journal of Gastroenterology and Hepatology
|
April 9, 2013
Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin
Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, et al.
Plos One
|
May 13, 2022
Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, et al.
Plos One
|
March 26, 2013
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients
Chung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Journal of Hepatology
|
June 28, 2011
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
Chung-Feng Huang, Jee-Fu Huang, Jeng-Fu Yang, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
December 19, 2012
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
Chung-Feng Huang, Ming-Lung Yu, Jia-Horng Kao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 19, 2017
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Tomi W Jun, Ming-Lun Yeh, Ju Dong Yang, et al.
Medicine
|
March 9, 2018
Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes
Ching-I Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
JHEP Reports : Innovation in Hepatology
|
December 30, 2025
Corrigendum to "Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study" [JHEP Reports 2025 7(10) 101516]
Edward Gane, Ewa Janczewska, Tetsuo Takehara, et al.
JHEP Reports : Innovation in Hepatology
|
September 8, 2025
Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study
Edward Gane, Ewa Janczewska, Tetsuo Takehara, et al.
Alimentary Pharmacology & Therapeutics
|
August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment
Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.
Page
of 46